Metabolomics and Network Pharmacology-Based Investigation into the Mechanisms Underlying the Therapeutic Effect of a New Chinese Traditional Medicine (Cui Nai Ling) on Bromocriptine-Induced Hypogalactia

• Published in: Evidence-based complementary and alternative medicine 2021, Vol.2021, p.8857449-17
• Main Authors: Meng, Xianglong, Lyu, Chenzi, Ma, Junnan, Zhang, Xiaoyan, Hu, Cong, Su, Xiaojuan, Ning, Chenxu, Xie, Wenbin, Zhang, Shuosheng
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Alternative medicine; Animal lactation; Antibiotics; Appetite loss; Biochemical analysis; Biotechnology; Body weight loss; Breast; Bromocriptine; Coronary vessels; Drug dosages; Dynasties; Glucose metabolism; Insulin; Insulin resistance; Lactation; Lipid metabolism; Mammary gland; Medulla oblongata; Metabolomics; Methionine; Pharmacodynamics; Phenylalanine; Postpartum; Prolactin; Rodents; Signal transduction; Thymus gland; Traditional medicine; Tryptophan; Tyrosine; Urea; Veterinary medicine
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2021/8857449

As a traditional veterinary medicine to promote lactation, Cui Nai Ling (CNL) can not only increase milk supply and promote health but also improve the overall physiological function and immunity of the animals. In order to further improve CNL’s effect on lactation, we have previously made a new CNL (NCNL) by adding Tetrapanacis Medulla and replacing Vaccariae Semen with fried Vaccariae Semen in CNL. We have demonstrated that the lactation-promoting effect of NCNL is better than that of CNL. However, the underlying mechanisms by which NCNL promotes lactation are unclear. In this study, we performed metabolomics, network pharmacology, and pharmacodynamic studies to explore the underlying mechanisms by which NCNL promotes lactation in rats with bromocriptine-induced hypogalactia. The results showed that NCNL significantly improved the loss of appetite in female adult rats and the weight loss of pups caused by the disorder of lactation. Biochemical analysis showed that NCNL could regulate the levels of PRL, T4, E2, Ca, UREA, GLU, ALT, AST, TCHO, and TG in serum. The pathological results showed that NCNL could promote lactation and increase the mammary gland index by improving breast acinar tissue morphology in rats with hypogalactia. Network pharmacology studies showed that NCNL promotes lactation through P13K-Akt, insulin resistance, and prolactin signaling pathways, among which the most frequently affected pathway was the P13K-Akt signaling pathway. Metabolomics studies showed that NCNL can significantly upregulate phenylalanine, tyrosine, and tryptophan biosynthesis and tyrosine metabolism pathways and downregulate cysteine and methionine metabolism pathways. NCNL can significantly increase the serum prolactin concentration, improve the glucose and lipid metabolism disorders, and regulate PI3K-Akt, insulin resistance, and prolactin pathways to affect the amino acids’ metabolism in the mammary gland and ultimately exert its therapeutic effect on bromocriptine-induced postpartum hypogalactia. These findings revealed the effect and application value of NCNL on animals with postpartum hypogalactia.